Related Experiment Videos
Viral hepatitis in older adults
1Acute Geriatric Department, Sarah Herzog Memorial Hospital, Jerusalem, Israel.
Journal of the American Geriatrics Society
|June 1, 1997
Summary
Viral hepatitis in older adults requires tailored prevention and treatment strategies. Vaccination for Hepatitis A (HAV) is recommended, while Hepatitis B (HBV) and C (HCV) management focuses on antiviral therapies for specific patient groups.
Area of Science:
- Geriatric Medicine
- Infectious Diseases
- Hepatology
Background:
- Viral hepatitis poses unique challenges in older populations.
- Hepatitis A virus (HAV) infection increases in morbidity and mortality with age.
- Hepatitis B virus (HBV) and Hepatitis C virus (HCV) present distinct epidemiological and therapeutic considerations in the elderly.
Purpose of the Study:
- To review the epidemiology, clinical manifestations, therapy, and prevention of viral hepatitis in older individuals.
- To discuss specific prevention and management issues for viral hepatitis in the aging population.
Main Methods:
- Literature review of viral hepatitis in older adults.
- Analysis of epidemiological data, clinical presentations, and treatment outcomes.
- Discussion of current and emerging therapeutic strategies, including vaccination and antiviral agents.
Main Results:
- Hepatitis A vaccine is safe and effective; immunization is recommended for older adults, including high-risk groups.
- Acute Hepatitis B is rare and mild; chronic HBV patients with advanced liver disease are not typically candidates for interferon therapy.
- Hepatitis C is common; antiviral therapy may benefit older patients with compensated liver disease, with combination therapy for non-responders.
Conclusions:
- Tailored vaccination and antiviral strategies are crucial for managing viral hepatitis in older adults.
- Further research into Hepatitis G virus (HGV) pathogenesis in the elderly is warranted.
- Age-related changes in immune response necessitate the development of more immunogenic vaccines.